K H Antman1, R L Souhami. Show Affiliations » 1. Harvard Medical School, Department of Medicine, Dana-Farber Cancer Institute, Boston, MA.
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/administration & dosageBreast Neoplasms/drug therapyCarcinoma, Small Cell/drug therapyClinical Trials, Phase II as TopicFemaleHumansLung Neoplasms/drug therapyNeoplasms/drug therapyNeoplasms, Germ Cell and Embryonal/drug therapyOvarian Neoplasms/drug therapyResearch Design
Substances: See more » Antineoplastic Agents
Year: 1993 PMID: 8393339 DOI: 10.1093/annonc/4.suppl_1.s29
Source DB: PubMed Journal: Ann Oncol ISSN: 0923-7534 Impact factor: 32.976